As new immunotherapies, antibody-drug conjugates, targeted therapies, and combination treatments are transforming the personalized care of patients with metastatic urothelial carcinoma (mUC), it is crucial to stay updated on the latest approvals, clinical efficacy and safety profiles, and strategies for managing treatment-related adverse events. In this engaging Clinical Case Challenge: utilize your clinical reasoning skills in real-world patient cases challenge your expertise in monitoring for and managing treatment-associated adverse events related to new and emerging therapies compare your performance to other healthcare professionals gain immediate feedback through expert-led, microlearning videos supported by key evidence. This activity is delivered in partnership with Cancer Care.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/gamified-approach-improve-individualized-care-advanced-metastatic-bladder
- Start Date: 2024-09-06 05:00:00
- End Date: 2024-09-06 05:00:00
- Credit Details: IPCE Credits: 0.25 hours
AAPA Category 1 Credit™️: 0.25 hours
AMA PRA Category 1 Credit™️: 0.25 hours
Nursing: 0.25 hours
Pharmacy: 0.25 hours - MOC Credit Details: ABIM - 0.25 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Gilead Sciences, Inc. - Amount: 36250.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Medical Oncology